Skip to main content
Figure 3 | Breast Cancer Research

Figure 3

From: Validation of the prognostic gene portfolio, ClinicoMolecular Triad Classification, using an independent prospective breast cancer cohort and external patient populations

Figure 3

The association between clinicopathological variables and the three CMTC groups in the 4,851 overall breast cancers. (A) ER status, (B) HER2/TN status, (C) patient age, (D) tumor size, (E) lymph node status and (F) tumor grade. The P values were determined using the Chi-square test and Fisher's exact test. CMTC, ClinicoMolecular Triad Classification; ER, estrogen receptor; HER2, human epidermal growth factor receptor 2; TN, triple negative.

Back to article page